Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > credibility issues ...
View:
Post by Ciao on Aug 29, 2023 9:42am

credibility issues ...

"The decrease in sales revenue for the first 6 months was primarily driven by an overall decrease in sales volume of 61% mainly due to a one-time stocking campaign by one major customer in 2022"

Q2 NR from 8/29/23 

vs. 


"We kicked off the year with the signing of a three-year renewable Supply and Distribution Agreement with leading global active ingredients provider, Symrise, which served as a major catalyst to our best ever financial performance year in the Company’s history."

Year end NR from 4/12/2023

A reasonable guess would be that the restructuring of J&J into separate divisions could have led them to purchase safety stock in H1 2022 to which they have realized over the past 4 quarters, they have way too much inventory now. 

A comment in H1 on the revenue surge of 35% could have been given, but it was not, lots of implications here.
Comment by boazklinghorn on Aug 29, 2023 9:51am
The Symrise deal supposedly has annual minimums but what are they?? If 6 month revenue is a shocking 5.5 million what is the contracted minimum for 2023. Again we have no idea but it would appear to be so low as to be nothing more than a talking point.
Comment by Alex1726 on Aug 29, 2023 9:55am
With Gagnon you'll never get the real picture , he doest not lie but he does not tell the truth. A nasdaq listing? I am not sure U.S. investors will appreciate his management.
Comment by boazklinghorn on Aug 29, 2023 10:03am
Who is paying for this 100L plant in europe? Yet another change on the fly before the plant in Edmonton is even started? And then an even bigger plant in Canada? What the hell is all this?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities